Celularity Inc. Form 8-K Summary
Business Context and Reporting Period
Company: Celularity Inc.
Filing Date: October 24, 2025
Reporting Period: Current Report (Event Date: October 24, 2025)
Event: Entry into a Material Definitive Agreement for a Private Placement of Series A Convertible Preferred Stock and Warrants.
Key Financial Metrics and Transaction Details
This filing details a capital raise rather than periodic financial performance. Key metrics include:
- Total Aggregate Stated Value: Up to $6,666,667 in Series A Preferred Stock.
- Initial Tranche Proceeds: $2,000,000 gross proceeds (90% of $2,222,222 stated value).
- Transaction Structure: Up to three tranches of $2,000,000 gross proceeds each.
- Dividend Rate: 5.0% per annum (payable quarterly in cash or PIK); increases to 18% per annum during a "Triggering Event."
- Use of Proceeds: Working capital and general corporate purposes.
- Security Interest: Investor granted a first priority security interest in certain company assets.
Material Changes and Transaction Terms
The company entered into a Securities Purchase Agreement with an institutional investor. Material terms include:
- Conversion Price: Lower of (i) 110% of the closing price prior to issuance or (ii) 95% of the lowest 7-day VWAP prior to conversion, subject to a floor price of $1.60 per share.
- Warrants: Issued for no additional consideration. Initial exercise price is $3.00 per share. Number of shares purchasable equals 25% of the tranche purchase price divided by 95% of the lowest 7-day VWAP.
- Redemption: Company may redeem at 120% of stated value plus accrued dividends. Holders may require redemption of up to 10% of net proceeds from future equity financings.
- Liquidation Preference: Senior to common stock; holders receive the greater of stated value plus accrued dividends or the conversion value.
- Ownership Limits: Beneficial ownership limited to 4.99% (increasable to 19.99% with notice) to prevent dilution without shareholder approval.
Outlook, Risks, and Contingencies
- Registration Rights: Company must file a registration statement for resale of conversion shares and warrants within 30 days and have it declared effective within 90 days.
- Future Closings: The Second Tranche is subject to the effectiveness of the resale registration statement for the Initial Tranche. The Third Tranche is at the Investor's option.
- Dilution Risk: Conversion price is subject to downward adjustment in dilutive issuances (e.g., stock splits, offerings below conversion price).
- Triggering Event: Specific events defined in the agreement can increase the dividend rate to 18% and potentially trigger the issuance of an Exchange Promissory Note.
Investor Verification Checklist
- Verify the current market price of CELU relative to the $1.60 conversion floor and $3.00 warrant exercise price.
- Confirm the status of the resale registration statement required for the Second Tranche closing.
- Review the definition of "Triggering Event" in the Certificate of Designation to assess the risk of the dividend rate increasing to 18%.
- Assess the impact of the first priority security interest on the company's ability to secure future financing.
- Monitor the company's cash burn rate to determine if the $2 million initial proceeds are sufficient for stated working capital needs.